Warren Buffett’s Berkshire Hathaway Takes $1.6B Stake in UNH Stock

Key Takeaways

• Berkshire Hathaway surprised markets by disclosing a new $1.6 billion stake in embattled insurer UnitedHealth despite ongoing regulatory challenges.
• UnitedHealth shares gapped up 11% in after-hours trading after Berkshire’s filing; the stock had dropped nearly 50% year-to-date before the news.
• Buffett’s team shuffled the portfolio, trimming Apple and Bank of America, as the conglomerate prepares for a leadership transition to Greg Abel.

Berkshire Reveals UnitedHealth Position

Warren Buffett’s Berkshire Hathaway (BRK.A) disclosed a significant new investment in UnitedHealth Group (UNH) last quarter, adding over 5 million shares valued at roughly $1.6 billion. The move, revealed in a quarterly regulatory filing, surprised market watchers given UnitedHealth’s recent struggles, including a Department of Justice probe into its Medicare billing practices and a sharp plunge in its share price.

Despite the turmoil, UnitedHealth’s inclusion now ranks as the 18th-largest holding in Berkshire’s equity portfolio, which is valued at around $300 billion. Shares of UnitedHealth soared 10% in extended trading after the news broke, reversing some of the nearly 50% year-to-date losses the insurer had suffered before the filing. The purchase underscores Berkshire’s continued focus on bargain opportunities, a hallmark of Buffett’s investing philosophy. However, it remains unclear whether the decision came directly from Buffett or his investment lieutenants, Todd Combs and Ted Weschler.

UnitedHealth (UNH) has faced numerous regulatory challenges this year. The company remains under investigation for allegedly inflating Medicare Advantage payments and was recently hit by a cyberattack that disrupted claims processing at its Change Healthcare unit. These headwinds contributed to its stock decline, which made it a contrarian pick for Berkshire Hathaway (BRK.A). The timing of Berkshire’s entry suggests its investment team may see value in UnitedHealth’s core business and its long-term growth prospects, even as short-term risks persist. Market analysts will be watching to see whether Berkshire increases its stake in the coming quarters or provides further commentary on its healthcare strategy.

Portfolio Shifts Reflect Market Trends

The UnitedHealth (UNH) stake was not the only notable move in Berkshire Hathaway’s (BRK.A) latest filing. The conglomerate also initiated new positions in steelmaker Nucor (NUE), homebuilders Lennar (LEN) and D.R. Horton (DHI), and advertising firm Lamar Advertising (LAMR), while returning to the homebuilding sector. Shares of Nucor jumped nearly 8% in after-hours trading, while Lennar and D.R. Horton each gained about 3% on the news.

Meanwhile, Berkshire trimmed its long-held stakes in Apple (AAPL) and Bank of America (BAC), reducing its Apple position by approximately 7%. As of the end of the second quarter, its largest holdings remained Apple, American Express (AXP), Bank of America, Coca-Cola (KO), and Chevron (CVX). The adjustments reflect a tactical reshuffling as Berkshire’s leadership prepares for transition and adapts to market volatility and sector-specific headwinds.

Berkshire’s (BRK.A) moves into cyclical sectors like steel and homebuilding appear to reflect a belief that the U.S. economy will remain resilient, despite higher interest rates and uncertainty about future consumer demand. The new bets on Nucor (NUE), Lennar (LEN), and D.R. Horton (DHI) signal confidence in American manufacturing and housing, sectors that have seen renewed investor interest amid expectations of infrastructure spending and a possible rebound in residential construction. The reduction in technology exposure, particularly in Apple (AAPL), may indicate some caution regarding lofty valuations or an effort to diversify as macroeconomic conditions shift. The overall portfolio activity suggests Berkshire is positioning itself for both defensive and opportunistic plays as market dynamics evolve.

Leadership Transition Adds Uncertainty

Berkshire Hathaway’s (BRK.A) evolving equity portfolio comes at a pivotal moment for the conglomerate. Warren Buffett, who turns 95 this month, will step down as CEO at year-end, with vice chairman Greg Abel set to take the top job. Buffett will remain as board chairman, but the future stewardship of Berkshire’s $300 billion equity portfolio remains to be fully clarified.

While Abel is expected to oversee capital allocation decisions, it is yet to be seen how much investment autonomy will remain with managers Todd Combs and Ted Weschler. The revelation of the UnitedHealth (UNH) stake, alongside other new positions, suggests that Berkshire’s investment team continues to seek value opportunities even in challenged sectors. However, with UnitedHealth facing regulatory headwinds and recent earnings disappointments, investors will watch closely for further signals as the leadership handover approaches.

Market participants are also closely monitoring how Abel’s leadership style and priorities may differ from Buffett’s, particularly regarding risk tolerance, sector focus, and the pace of portfolio turnover. The recent shuffling, including both defensive and contrarian bets, may hint at a more dynamic approach under the coming regime. As Berkshire (BRK.A) navigates this transition period, analysts expect increased scrutiny of its quarterly filings for insight into the evolving investment strategy and risk appetite. The coming quarters will be critical for establishing confidence in Abel and the broader management team’s ability to maintain Berkshire’s track record of disciplined capital allocation.